Jing-Yu Fan Selected Research

qishen yiqi

1/2021	QiShenYiQi Inhibits Tissue Plasminogen Activator-Induced Brain Edema and Hemorrhage after Ischemic Stroke in Mice.
1/2021	QiShenYiQi Pills Attenuates Ischemia/Reperfusion-Induced Cardiac Microvascular Hyperpermeability Implicating Src/Caveolin-1 and RhoA/ROCK/MLC Signaling.
1/2019	A novel traditional Chinese medicine ameliorates fatigue-induced cardiac hypertrophy and dysfunction via regulation of energy metabolism.
1/2019	QiShenYiQi Pills® ameliorates ischemia/reperfusion-induced myocardial fibrosis involving RP S19-mediated TGFβ1/Smads signaling pathway.
1/2019	Effects and mechanisms of QiShenYiQi pills and major ingredients on myocardial microcirculatory disturbance, cardiac injury and fibrosis induced by ischemia-reperfusion.
1/2018	The Contribution of Different Components in QiShenYiQi Pills® to Its Potential to Modulate Energy Metabolism in Protection of Ischemic Myocardial Injury.
1/2017	QiShenYiQi Pills, a Compound Chinese Medicine, Prevented Cisplatin Induced Acute Kidney Injury via Regulating Mitochondrial Function.
7/2015	QiShenYiQi Pills, a compound in Chinese medicine, protects against pressure overload-induced cardiac hypertrophy through a multi-component and multi-target mode.
9/2013	QiShenYiQi Pills® prevent cardiac ischemia-reperfusion injury via energy modulation.
1/2013	QiShenYiQi Pills, a Compound Chinese Medicine, Ameliorates Doxorubicin-Induced Myocardial Structure Damage and Cardiac Dysfunction in Rats.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jing-Yu Fan Research Topics

Disease

25	Ischemia 06/2022 - 01/2008
14	Edema (Dropsy) 06/2022 - 04/2012
10	Reperfusion Injury 01/2021 - 08/2009
6	Hemorrhage 01/2022 - 05/2011
5	Body Weight (Weight, Body) 01/2022 - 05/2011
5	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 04/2010
5	Brain Edema (Cerebral Edema) 01/2021 - 04/2012
5	Ischemic Stroke 01/2021 - 10/2012
4	Inflammation (Inflammations) 01/2021 - 05/2013
4	Cardiomegaly (Heart Hypertrophy) 01/2021 - 01/2012
4	Fibrosis (Cirrhosis) 01/2019 - 01/2012
4	Lung Injury 01/2018 - 03/2013
4	Thrombosis (Thrombus) 09/2017 - 01/2006
3	Hypoxia (Hypoxemia) 01/2022 - 01/2018
3	Respiratory Tract Diseases (Respiratory Tract Disease) 01/2022 - 10/2014
3	Myocardial Ischemia (Ischemic Heart Diseases) 01/2021 - 01/2018
3	Infarction (Infarctions) 01/2021 - 04/2010
3	Myocardial Infarction 01/2018 - 04/2010
2	Rupture 01/2021 - 09/2013
2	Endotoxemia 01/2019 - 10/2013
2	Cognitive Dysfunction 01/2018 - 01/2018
2	Non-alcoholic Fatty Liver Disease 08/2017 - 01/2015
2	Colitis 01/2017 - 01/2013
2	Acute Lung Injury 12/2016 - 11/2014
2	Cerebral Infarction 01/2016 - 06/2015
2	Brain Ischemia (Cerebral Ischemia) 06/2015 - 10/2012
1	Infections 06/2022
1	Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal) 01/2021
1	Carotid Artery Thrombosis 01/2021
1	Stroke (Strokes) 01/2021
1	Brain Infarction 01/2021

Drug/Important Bio-Agent (IBA)

13	AlbuminsIBA 06/2022 - 04/2012
12	Proteins (Proteins, Gene)FDA Link 06/2022 - 04/2010
11	qishen yiqiIBA 01/2021 - 01/2012
9	Evans Blue (Blue, Evans)FDA Link 01/2021 - 04/2012
8	Adenosine Triphosphate (ATP)IBA 06/2022 - 01/2013
6	Cardiotonic Agents (Cardiac Stimulants)IBA 01/2019 - 01/2006
6	AntioxidantsIBA 01/2019 - 01/2009
5	Claudin-5IBA 01/2021 - 10/2012
5	Lactic Acid (Lactate)FDA LinkGeneric 01/2021 - 01/2009
5	CollagenIBA 01/2019 - 01/2012
5	Adenosine Monophosphate (AMP)IBA 01/2018 - 01/2013
5	CytokinesIBA 01/2018 - 10/2014
4	astragaloside AIBA 06/2022 - 11/2013
4	OccludinIBA 01/2022 - 10/2012
4	notoginsenoside R1IBA 01/2021 - 01/2008
4	LipopolysaccharidesIBA 01/2019 - 02/2014
4	Adenosine Diphosphate (ADP)IBA 01/2018 - 09/2013
4	NADPH Oxidases (NAD(P)H oxidase)IBA 01/2017 - 01/2013
3	cadherin 5IBA 01/2022 - 01/2017
3	Caveolin 1IBA 01/2021 - 10/2012
3	SirtuinsIBA 01/2021 - 08/2015
3	yi-qi-fu-maiIBA 01/2021 - 09/2009
3	salvianolic acidIBA 01/2019 - 11/2010
3	Insulin (Novolin)FDA Link 01/2019 - 01/2015
3	Sirtuin 3IBA 01/2019 - 08/2015
3	src-Family KinasesIBA 01/2018 - 06/2015
3	caffeic acidIBA 09/2015 - 04/2012
2	Tissue Plasminogen Activator (Alteplase)FDA Link 01/2021 - 01/2018
2	Actins (F Actin)IBA 01/2021 - 01/2018
2	Connexin 43 (Connexin43)IBA 01/2021 - 01/2019
2	Matrix Metalloproteinases (MMPs)IBA 01/2021 - 01/2019
2	Eosine Yellowish-(YS) (Eosin)IBA 01/2019 - 02/2014
2	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2019 - 01/2013
2	oxidized low density lipoproteinIBA 01/2019 - 01/2018
2	Triglycerides (Triacylglycerol)IBA 01/2019 - 08/2017
2	Hematoxylin (Haematoxylon)IBA 01/2019 - 02/2014
2	Laminin (Merosin)IBA 01/2018 - 12/2016
2	Silybin (Lagosa)IBA 01/2018 - 08/2017
2	sym-trinitrobenzeneIBA 01/2017 - 01/2013
2	Tight Junction ProteinsIBA 01/2017 - 10/2012
2	Sulfonic AcidsIBA 01/2017 - 01/2013
2	Pharmaceutical PreparationsIBA 10/2014 - 04/2010
2	salvianolic acid BIBA 03/2013 - 01/2009
2	Caspase 3 (Caspase-3)IBA 04/2012 - 04/2010
2	DNA Nucleotidylexotransferase (Terminal Deoxynucleotidyl Transferase)IBA 04/2012 - 04/2010
2	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 05/2011 - 04/2010
1	Small Interfering RNA (siRNA)IBA 06/2022
1	Claudin-3IBA 01/2022
1	ClaudinsIBA 01/2022
1	PowdersIBA 01/2022
1	CateninsIBA 01/2022
1	oligomycin sensitivity-conferring protein (complex V)IBA 01/2021
1	rho-Associated KinasesIBA 01/2021
1	Fluorescein-5-isothiocyanate (FITC)IBA 01/2021
1	CaveolinsIBA 01/2021
1	Dehydroepiandrosterone (DHEA)IBA 01/2021
1	Electron Transport Complex I (NADH-CoQ Reductase)IBA 01/2021
1	ferric chlorideIBA 01/2021
1	CXC ChemokinesIBA 01/2019
1	lardIBA 01/2019
1	ribosomal protein S19IBA 01/2019
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 01/2019
1	Capecitabine (Xeloda)FDA Link 01/2019
1	Cell Adhesion Molecule-1IBA 01/2019
1	Sirtuin 1IBA 01/2019

Therapy/Procedure

8	Chinese Traditional Medicine (Traditional Chinese Medicine) 01/2022 - 01/2009
3	Therapeutics 01/2021 - 10/2012
2	Lasers (Laser) 01/2013 - 01/2012
1	Drug Therapy (Chemotherapy) 01/2021